Exact Mass: 294.09970660000005
Exact Mass Matches: 294.09970660000005
Found 39 metabolites which its exact mass value is equals to given mass value 294.09970660000005,
within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error
0.0002 dalton.
Tyrphostin B42
C17H14N2O3 (294.10043740000003)
D000970 - Antineoplastic Agents > D020032 - Tyrphostins D004791 - Enzyme Inhibitors
Rosoxacin
C17H14N2O3 (294.10043740000003)
Rosoxacin is a quinolone derivative antibiotic for the treatment of bacterial infection of respiratory tract, urinary tract, GI, CNS and immuno compromised patients. Rosoxacin is known to be effective against penicillin resistant strains and is a single dose orally administered drug, which avoids all complications of parenteral administration seen with penicillin, especially anaphylactic shock. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000890 - Anti-Infective Agents
Tyrphostin B42
C17H14N2O3 (294.10043740000003)
1,2-Methylendioxy-6-nitroso-6abeta-aporphan|1,2-methylenedioxy-6-nitroso-6abeta-aporphane|5H-benzo[g]-1,3-benzodioxolo[5,6,4]quinoline-6,7,7a,8-tetrahydro-7-nitroso-(7aR)|N-nitrosoanonaine
C17H14N2O3 (294.10043740000003)
AG-490
C17H14N2O3 (294.10043740000003)
C17H14N2O3_(3S,3R)-4-Methyl-3-phenylspiro[1,4-benzodiazepine-3,2-oxirane]-2,5(1H,4H)-dione
C17H14N2O3 (294.10043740000003)
rosoxacin
C17H14N2O3 (294.10043740000003)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000890 - Anti-Infective Agents
5-(4-(Benzyloxy)phenyl)-1H-pyrazole-3-carboxylic acid
C17H14N2O3 (294.10043740000003)
(2-FLUORO-PHENYLAMINO)-ACETICACIDHYDRAZIDE
C17H14N2O3 (294.10043740000003)
2-Amino-3-phthalimid-1-ylpropiophenone
C17H14N2O3 (294.10043740000003)
1-BENZYL-2-OXO-1,2-DIHYDRO-1,8-NAPHTHYRIDIN-4-YL ACETATE
C17H14N2O3 (294.10043740000003)
(z)-3,4-dihydro-3-(2-(4-methoxyphenyl)-2-oxoethylidene)quinoxalin-2(1h)-one
C17H14N2O3 (294.10043740000003)
2-oxo-2-(5-phenylmethoxy-1H-indol-3-yl)acetamide
C17H14N2O3 (294.10043740000003)
2-(4-METHOXY-PHENYL)-5-PHENYL-2H-PYRAZOLE-3-CARBOXYLIC ACID
C17H14N2O3 (294.10043740000003)
1-(4-METHOXYPHENYL)-5-PHENYL-1H-PYRAZOLE-3-CARBOXYLIC ACID
C17H14N2O3 (294.10043740000003)
1H-Indole-3-carboxaldehyde,2-methyl-1-[(2-nitrophenyl)methyl]-(9CI)
C17H14N2O3 (294.10043740000003)
1H-Indole,3-(2-nitroethenyl)-5-(phenylmethoxy)-
C17H14N2O3 (294.10043740000003)
1H-Indole-3-carboxaldehyde,2-methyl-1-[(3-nitrophenyl)methyl]-(9CI)
C17H14N2O3 (294.10043740000003)
Phccc
C17H14N2O3 (294.10043740000003)
PHCCC is a Group I mGluR antagonist with an IC50 of 3 μM. PHCCC is a selective positive modulator of mGlu4 receptor. Antiparkinsonian effect[1][2].
2-[(1-Acetyl-1H-indol-3-YL)amino]benzoic acid
C17H14N2O3 (294.10043740000003)
3-[3-(5-methylfuran-2-yl)-1-phenyl-1H-pyrazol-4-yl]prop-2-enoic acid
C17H14N2O3 (294.10043740000003)
7-Methoxy-2-phenylimino-1-benzopyran-3-carboxamide
C17H14N2O3 (294.10043740000003)
(E/Z)-AG490
C17H14N2O3 (294.10043740000003)
(3s,3's)-2-hydroxy-4-methyl-3'-phenylspiro[1,4-benzodiazepine-3,2'-oxiran]-5-one
C17H14N2O3 (294.10043740000003)
3-acetyl-2-[(4-hydroxyphenyl)methyl]quinazolin-4-one
C17H14N2O3 (294.10043740000003)
2-hydroxy-4-methyl-3'-phenylspiro[1,4-benzodiazepine-3,2'-oxiran]-5-one
C17H14N2O3 (294.10043740000003)
(3'r)-2-hydroxy-4-methyl-3'-phenylspiro[1,4-benzodiazepine-3,2'-oxiran]-5-one
C17H14N2O3 (294.10043740000003)
(3r,3's)-2-hydroxy-4-methyl-3'-phenylspiro[1,4-benzodiazepine-3,2'-oxiran]-5-one
C17H14N2O3 (294.10043740000003)